Latest Breaking News On - அர்ஜென் பிரிந்க்மன் - Page 1 : comparemela.com
Een duurzame vakantie vieren in een dijk, dan ben je pas milieuvriendelijk
omroepzeeland.nl - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from omroepzeeland.nl Daily Mail and Mail on Sunday newspapers.
Duitsers laten zich niet afschrikken door code rood
omroepzeeland.nl - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from omroepzeeland.nl Daily Mail and Mail on Sunday newspapers.
Zeeuwse recreatieondernemers niet bang voor reispas: Geen enkel effect op onze bezetting
omroepzeeland.nl - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from omroepzeeland.nl Daily Mail and Mail on Sunday newspapers.
Blije ondernemer, blije campinggasten: We vermaken ons wel in Zeeland
omroepzeeland.nl - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from omroepzeeland.nl Daily Mail and Mail on Sunday newspapers.
Merus N.V.
Merus Announces Presentation of Phase 1 Clinical Data for MCLA-158 at the American Society of Clinical Oncology (ASCO) 2021 Gastrointestinal Cancers Symposium
Merus Announces Presentation of Phase 1 Clinical Data for MCLA-158 at the American Society of Clinical Oncology (ASCO) 2021 Gastrointestinal Cancers Symposium
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Jan. 11, 2021 (GLOBE NEWSWIRE) Merus N.V. (Nasdaq: MRUS) (“Merus”, “the Company”, “we”, or “our”), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics
® and Triclonics™), today announced that clinical data from its Phase 1 dose escalation study of MCLA-158 will be presented in a poster session at the American Society of Clinical Oncology (ASCO) 2021 Gastrointestinal Cancers Symposium (ASCO GI) annual meeting being held virtually from January 15-17, 2021.